Irma Gigli Distinguished Professor; Chairman, Department of Dermatology; University of California, San Diego
Dr. Richard Gallo is a world-famous American physician-scientist whose research contributions have brought greater understanding of human immunology and skin diseases. He was trained in Dermatology at Harvard and is now Chairman of Dermatology at the University of California, San Diego. His groundbreaking research discovered the existence of antimicrobial peptides in mammalian skin and has revolutionized understanding the function of the skin microbiome in human health. These research breakthroughs have greatly advanced understanding of several human diseases including atopic dermatitis, rosacea and more recently, acne. He has received major awards from the Society of Investigative Dermatology, the Japanese Society of Investigative Dermatology, the European Societies of Investigative Dermatology as well as several other scientific organizations outside of the field of Dermatology. He has been elected as a fellow of multiple prestigious societies including the American Association for the Advancement of Science, the American Association of Microbiology, the American Association of Clinical Investigation and the American Dermatology Association. Dr. Gallo is one of the highest cited active investigators in Medicine, with over 30,000 citations of more than 350 publications in the many of the most prestigious journals including: Nature, Science, New England J. of Medicine, Immunity, Cell Host and Microbe and others.
Professor Harald Gollnick is the former Director and Head of Department Dermatology and Venereology at Otto-von-Guericke University Magdeburg in Germany. His clinical and laboratory research is dedicated to retinoids, psoriasis, borreliosis, hair, acne, photobiology, skin cancer, dermatopathology and medical devices technology.
Dr Gollnick is past president of the German Society Dermatology, the European Section and Board Union of European Medical Specialists and of the European Dermatology Forum. He serves as a permanent member of the Scientific Board for the Berlin Foundation of Dermatology and German Dermatology Society Board. Dr Gollnick has implemented the harmonised European curriculum for residents and is currently working on the harmonisation of the undergraduate training in DermVen for Europe (Erasmus program).
He has investigating pathophysiology, biochemistry, clinical efficacy and adverse event profile including research on serum lipids, in cell culture models and in psychosomatics for acne. Dr Gollnick has demonstrated the mechanisms of insulin and insulin growth factor excess on the expression of TLR 2 and 4 on sebocytes and stimulation of growth of sebocytes in addition to androgens. A link to the carbohydrate excess in diets and provocation or deterioration of acne could be also found. Recently, he became interested in microbiota transplantation as a new tool for topical acne treatment.